Friday, January 22, 2021 4:40:47 PM
Yes you could very well be right and I'm open to that. I'm not questioning their need for money. What I'm concerned about, and it's just a concern, is that when management puts up a stock offering the goal is to have the highest possible stock price...correct? That's the point, to raise as much money as possible while issuing the fewest amount of shares. This is my question, and it's only a question not a statement, does management not believe their SP will be higher in another month? If so, that would be a prime reason to have the offering now just as they have done. Yes there could be other reasons and boy I hope there are. They'll have a strong position in the ETF and interim phase 3 results are close. These are two catalysts that should pump the SP...yes? So again, does management not believe their SP will be higher in another month? Why? One answer would be negative interim phase 3 results that push the SP down. But another prime reason for the offering would be exactly what you said, they need the money now, like right now. Trust me I hope that's what it is. I hope you are right and I am wrong.
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
